This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Oct;49(10):1180.

doi: 10.3899/jrheum.220179. Epub 2022 Jun 15.

Dr. Deng et al reply

Hao Deng¹, Xiu Hong Yang¹, Hui Min Jin²

Affiliations

Affiliations

¹ Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China.
² Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China. hmjgli@163.com.

PMID: 35705236
DOI: 10.3899/jrheum.220179

Comment

Dr. Deng et al reply

Hao Deng et al. J Rheumatol. 2022 Oct.

. 2022 Oct;49(10):1180.

doi: 10.3899/jrheum.220179. Epub 2022 Jun 15.

Authors

Hao Deng¹, Xiu Hong Yang¹, Hui Min Jin²

Affiliations

¹ Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China.
² Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China. hmjgli@163.com.

PMID: 35705236
DOI: 10.3899/jrheum.220179

No abstract available

PubMed Disclaimer

Comment on

Febuxostat Use and Safety in Patients With Hyperuricemia.
Kawada T. Kawada T. J Rheumatol. 2022 Oct;49(10):1180. doi: 10.3899/jrheum.220147. Epub 2022 Jun 15. J Rheumatol. 2022. PMID: 35705244 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire